Abbott Laboratories (ABT) — Analysis Summary
Abbott Laboratories (ABT) has a market cap of $152.25B with year-over-year revenue growth of +5.7%. Net margin stands at 14.7%. The stock trades at a P/E ratio of 24.3.
Key Takeaways
- Revenue changed +5.7% year-over-year
- Net margin of 14.7%
- P/E ratio of 24.3
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ABT posted revenue growth of +5.7% and trades at a P/E of 24.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.